The University of Cambridge invites applications for a PhD project focused on deciphering resistance mechanisms to KRAS inhibition in pancreatic cancer. The project uses organoid cultures and mouse models, with single-cell RNA sequencing and spatial transcriptomics to define intra-tumour heterogeneity and stromal interactions.
Preference given to candidates with experience in tissue culture, IHC, Western blotting, PCR, and familiarity with PDAC biology.
#J-18808-Ljbffr
PhD: Fully Funded KRAS Resistance in Pancreatic Cancer in Cambridge employer: University of Cambridge
The University of Cambridge offers a dynamic and collaborative work environment, particularly within the Department of Oncology, where you will play a pivotal role in advancing cancer research. With a strong emphasis on employee growth, you will have access to professional development opportunities and the chance to work alongside leading experts in the field. The university's commitment to innovation and excellence ensures that your contributions will have a meaningful impact on clinical care and research outcomes.
